1166568--12/24/2009--ALION_SCIENCE_&_TECHNOLOGY_CORP

related topics
{regulation, government, change}
{customer, product, revenue}
{debt, indebtedness, cash}
{cost, contract, operation}
{personnel, key, retain}
{acquisition, growth, future}
{control, financial, internal}
{cost, operation, labor}
{product, market, service}
{loss, insurance, financial}
{condition, economic, financial}
{cost, regulation, environmental}
{competitive, industry, competition}
{system, service, information}
We could incur adverse effects from our prior disclosure relating to our compliance with our financial covenants. Despite our current debt levels, we and our subsidiaries may still be able to incur more debt. This could further aggravate risks associated with our substantial leverage. Our Term B Senior Credit Agreement and the Senior Unsecured Note Indenture will restrict our operations. We may not be able to obtain financing in the future, and the terms of any future financings may limit our ability to manage our business. Difficulties in obtaining financing on favorable terms would have a negative effect on our ability to execute our business strategy. We may be required to amend the financial covenants of our Term B Senior Credit Agreement which could materially impact our ability to finance our future operations, future acquisitions or capital needs. We expect to experience net losses in at least our next four years of operation. Our ability to meet our financial and other future obligations depends on our future operating results. We cannot be sure we will be able to meet these obligations as they come due. We face intense competition from many companies that have greater resources than we do. This could cause price reductions, reduced profitability, and loss of market share. Historically, a few contracts have provided most of our revenue. If we do not retain or replace these contracts our operations will suffer. If we are unable to manage our growth, our business could be adversely affected. Acquisitions could increase our costs or liabilities or be disruptive. Due to the inherent danger involved in some of the businesses that we conduct, there are risks of claims by clients and third parties that could have a substantial adverse economic impact upon us. We depend on key management and may not be able to retain those employees due to competition for their services. Our business could suffer if we fail to attract, train and retain skilled employees. In order to succeed, we will have to keep up with rapid technological changes in a number of industries. Various factors could impact our ability to keep pace with these changes. An economic downturn could harm our business. Our employees may engage in misconduct or other improper activities, which could harm our business. The interests of the ESOP Trust may not be aligned with the interests of participants in the ESOP component of the KSOP. Environmental laws and regulations and our use of hazardous materials may subject us to significant liabilities. Risks Related to Our Industry We depend on U.S. government contracts for substantially all of our revenue. Changes in the contracting or fiscal policies of the U.S. government could adversely affect our business, financial condition or results of operations. Failure by Congress to timely approve budgets for the federal agencies we support could delay or reduce spending and cause us to lose revenue. We may not realize the full amount of our backlog, which could lower future revenue. Many of our U.S. government customers procure goods and services through ID/IQ, GWAC or GSA Schedule contracts under which we must compete for post-award orders. U.S. government contracts contain termination provisions that are unfavorable to us. If we do not accurately estimate the expenses, time and resources necessary to meet our contractual obligations, our contract profits will be lower than expected. Our operating margins and operating results may suffer if cost-reimbursement contracts increase in proportion to our total contract mix. If our fixed-price contract revenue declines in total or as a proportion of our total business, or if profit rates on these contracts deteriorate, our operating margins and operating results may suffer. Our subcontractors failure to perform contractual obligations could damage our reputation as a prime contractor and our ability to obtain future business. Because U.S. government contracts are subject to government audits, contract payments are subject to adjustment and repayment which may result in revenue attributed to a contract being lower than expected. If we fail to recover at- risk contract costs, it may result in reduced fees or in losses. Actual or perceived conflicts of interest may prevent us from being able to bid on or perform contracts. As a U.S. government contractor, we must comply with complex procurement laws and regulations and our failure to do so could have a negative impact upon our business. We derive significant revenue from U.S. government contracts awarded through competitive bidding which is an inherently unpredictable process.

Full 10-K form ▸

related documents
1166568--12/28/2007--ALION_SCIENCE_&_TECHNOLOGY_CORP
1166568--12/23/2008--ALION_SCIENCE_&_TECHNOLOGY_CORP
1166568--12/14/2010--ALION_SCIENCE_&_TECHNOLOGY_CORP
886171--3/12/2009--UNIVERSAL_HOSPITAL_SERVICES_INC
886171--3/11/2008--UNIVERSAL_HOSPITAL_SERVICES_INC
886171--3/10/2010--UNIVERSAL_HOSPITAL_SERVICES_INC
886171--3/16/2007--UNIVERSAL_HOSPITAL_SERVICES_INC
886171--3/31/2006--UNIVERSAL_HOSPITAL_SERVICES_INC
1157972--2/16/2006--DJ_ORTHOPEDICS_INC
1170650--2/19/2008--MEDCO_HEALTH_SOLUTIONS_INC
813562--9/13/2006--NATIONAL_MEDICAL_HEALTH_CARD_SYSTEMS_INC
1360474--4/2/2007--CRC_Health_CORP
927066--2/28/2007--DAVITA_INC
929994--3/6/2009--ASSISTED_LIVING_CONCEPTS_INC
1047699--2/29/2008--KING_PHARMACEUTICALS_INC
1047335--3/2/2010--NATIONAL_HEALTHCARE_CORP
1047335--3/17/2008--NATIONAL_HEALTHCARE_CORP
1087216--12/22/2010--Access_Plans_Inc
1047699--3/1/2007--KING_PHARMACEUTICALS_INC
1145238--9/22/2009--INSIGHT_HEALTH_SERVICES_HOLDINGS_CORP
1047335--3/16/2007--NATIONAL_HEALTHCARE_CORP
19584--2/28/2007--CHEMED_CORP
896262--2/17/2009--AMEDISYS_INC
26076--12/9/2010--CUBIC_CORP_/DE/
352915--2/26/2009--UNIVERSAL_HEALTH_SERVICES_INC
1179929--3/14/2007--MOLINA_HEALTHCARE_INC
867963--9/24/2009--UNITED_AMERICAN_HEALTHCARE_CORP
26076--12/9/2009--CUBIC_CORP_/DE/
927066--3/6/2006--DAVITA_INC
853971--4/17/2006--STANDARD_MANAGEMENT_CORP